Yarrow Bioscience (YARW) Inventory Average (2020 - 2021)
Yarrow Bioscience's (YARW) quarterly Inventory Average came in at $7.7 million in Q4 2021, up 9.3% YoY from $7.0 million in Q4 2020, and down 6.04% on a QoQ basis from $8.2 million in Q3 2021.
Yarrow Bioscience (YARW) Inventory Average (2020 - 2021) Analysis & Trends
Yarrow Bioscience (YARW) has 2 years of Inventory Average data on file, last reported at $7.7 million in Q4 2021.
- Quarterly Inventory Average rose 9.3% year-over-year to $7.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $7.7 million (up 9.3% YoY) and the FY2021 annual result came in at $7.3 million, up 67.75% from the prior year.
- Inventory Average fell to $7.7 million in Q4 2021, from $8.2 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $8.2 million in Q2 2021 to a low of $2.3 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | - |
| 10 | Yarrow Bioscience | 31.22 Mn | 8.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 7.68 Mn |
| Sep 30, 2021 | 8.17 Mn |
| Jun 30, 2021 | 8.19 Mn |
| Mar 31, 2021 | 7.75 Mn |
| Dec 31, 2020 | 7.03 Mn |
| Sep 30, 2020 | 6.23 Mn |
| Jun 30, 2020 | 4.50 Mn |
| Mar 31, 2020 | 2.28 Mn |